PlainRecalls
FDA Devices Moderate Class II Terminated

SUNG HWAN E&B VIVACE Shenb Innovation of Beauty Technologyt - Product Usage: intended for use in the dermatologic and surgical procedures for electrocoagulation and hemostasis, and the percutaneous treatment of facial wrinkles.

Reported: November 18, 2020 Initiated: March 13, 2020 #Z-0444-2021

Product Description

SUNG HWAN E&B VIVACE Shenb Innovation of Beauty Technologyt - Product Usage: intended for use in the dermatologic and surgical procedures for electrocoagulation and hemostasis, and the percutaneous treatment of facial wrinkles.

Reason for Recall

A high frequency output (2 MHz) has not been cleared for distribution in the U.S.

Details

Units Affected
623 units
Distribution
U.S. Nationwide distribution including in the states of AL, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NM, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI, and WY.
Location
Phoenix, AZ

Frequently Asked Questions

What product was recalled?
SUNG HWAN E&B VIVACE Shenb Innovation of Beauty Technologyt - Product Usage: intended for use in the dermatologic and surgical procedures for electrocoagulation and hemostasis, and the percutaneous treatment of facial wrinkles.. Recalled by Aesthetics Biomedical, Inc.. Units affected: 623 units.
Why was this product recalled?
A high frequency output (2 MHz) has not been cleared for distribution in the U.S.
Which agency issued this recall?
This recall was issued by the FDA Devices on November 18, 2020. Severity: Moderate. Recall number: Z-0444-2021.